Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,321,450 papers from all fields of science
Search
Sign In
Create Free Account
LY 121019
Known as:
LY-121019
, LY121019
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
cilofungin
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
1990
1990
Comparative effects of cilofungin and amphotericin B on experimental murine candidiasis
C. J. Morrison
,
D. Stevens
Antimicrobial Agents and Chemotherapy
1990
Corpus ID: 7905669
The effectiveness of cilofungin (LY121019, referred to hereafter as LY), a lipopeptide, was studied in a murine candidiasis model…
Expand
1990
1990
Cilofungin (LY121019) shows nonlinear plasma pharmacokinetics and tissue penetration in rabbits
J. Lee
,
P. Kelly
,
+4 authors
T. Walsh
Antimicrobial Agents and Chemotherapy
1990
Corpus ID: 1899523
We studied the plasma pharmacokinetics and tissue penetration of cilofungin (LY121019), a new echinocandin antifungal compound…
Expand
1990
1990
Retinal toxicity and in vitro efficacy study of cilofungin (LY121019).
M. Shahsavari
,
G. Peyman
,
M. Niesman
Ophthalmic surgery
1990
Corpus ID: 41978283
We assessed the retinal toxicity of a new antifungal agent, cilofungin, by injecting it into the vitreous body of albino rabbit…
Expand
1989
1989
Effects of cilofungin (LY121019) on carbohydrate and sterol composition ofCandida albicans
M. Pfaller
,
J. Riley
,
T. Koerner
European Journal of Clinical Microbiology and…
1989
Corpus ID: 1803131
Cilofungin (LY121019) is a novel analogue of echinocandin B with potent activity againstCandida albicans. The effects of…
Expand
1989
1989
Evaluation of cilofungin, a lipopeptide antifungal agent, in vitro against fungi isolated from clinical specimens
L. H. Hanson
,
D. Stevens
Antimicrobial Agents and Chemotherapy
1989
Corpus ID: 21562471
Cilofungin (LY121019) is a new lipopeptide antifungal drug. We tested this drug against 141 pathogenic fungal isolates. All…
Expand
1989
1989
Susceptibility of nosocomial isolates of Candida species to LY121019 and other antifungal agents.
M. Pfaller
,
S. Wey
,
T. Gerarden
,
A. Houston
,
R. Wenzel
Diagnostic microbiology and infectious disease
1989
Corpus ID: 45189101
1989
1989
Susceptibility of Candida Species to Cilofungin (LY‐121019)
J. M. Torres-Rodríguez
,
A. Carrillo-Muñoz
,
C. Gallach-Bau
,
N. Madrenys
Mycoses (Berlin)
1989
Corpus ID: 43141421
Summary: The antifungal activity of a new semi‐synthetic lipopeptide named cilofungin (LY‐121019) was studied in vitro on 102…
Expand
1989
1989
In-vitro activity of cilofungin (LY121019) in comparison with amphotericin B.
F. Meunier
,
C. Lambert
,
P. van der Auwera
Journal of Antimicrobial Chemotherapy
1989
Corpus ID: 25381158
The in-vitro activity of cilofungin, a derivative of echinocandin B, was compared with that of amphotericin B in Sabouraud…
Expand
1988
1988
LY121019 inhibits Neurospora crassa growth and (1-3)-beta-D-glucan synthase.
C. Taft
,
C. Selitrennikoff
Journal of antibiotics (Tokyo. )
1988
Corpus ID: 39116205
KhpV 60 //M13); Neurospora crassa, Ki&VJ> 12 ^M (C. S. Taft; unpublished results); echinocandin B noncompetitive inhibitor…
Expand
1988
1988
Influence of in vitro susceptibility testing conditions on the anti-candidal activity of LY121019.
M. Pfaller
,
T. Gerarden
,
Mei Yu
,
R. Wenzel
Diagnostic microbiology and infectious disease
1988
Corpus ID: 2356394
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE